The Long Term Game Is Not Unimportant

James melory: What should roch be doing to day to build the capabilities so that weare the ones who are leading in 20 30, forty ars from now? I think you're getting at some of these different motalities, small molecules for arna targets and alisteric binders and protein degraders. To anabw you to approach different novel targets, for sure. James melory: The short turm game is not unimportant. It's just that if you truly want to build a really important health care company, you have to think in multiple different time frames. And most companies do not think in the longest of time frames.